Clarius Group LLC lifted its position in shares of Cigna Group (NYSE:CI - Free Report) by 59.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,859 shares of the health services provider's stock after acquiring an additional 1,446 shares during the quarter. Clarius Group LLC's holdings in Cigna Group were worth $1,270,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in CI. TCTC Holdings LLC bought a new stake in Cigna Group in the fourth quarter valued at about $25,000. Putney Financial Group LLC acquired a new position in Cigna Group in the fourth quarter valued at about $36,000. Transce3nd LLC acquired a new position in Cigna Group in the fourth quarter valued at about $38,000. Ameriflex Group Inc. acquired a new position in Cigna Group in the fourth quarter valued at about $44,000. Finally, Heck Capital Advisors LLC acquired a new position in Cigna Group in the fourth quarter valued at about $53,000. Institutional investors own 86.99% of the company's stock.
Cigna Group Stock Performance
NYSE:CI traded up $1.83 on Thursday, hitting $314.34. The company's stock had a trading volume of 1,170,259 shares, compared to its average volume of 1,715,859. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average of $322.05 and a two-hundred day moving average of $308.09. The firm has a market capitalization of $83.97 billion, a P/E ratio of 17.41, a price-to-earnings-growth ratio of 0.93 and a beta of 0.44. Cigna Group has a one year low of $262.03 and a one year high of $370.83.
Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.47 earnings per share. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were paid a $1.51 dividend. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 annualized dividend and a yield of 1.92%. Cigna Group's dividend payout ratio is 33.44%.
Analyst Ratings Changes
CI has been the subject of a number of research analyst reports. Royal Bank Of Canada reissued an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Tuesday, June 3rd. Piper Sandler boosted their target price on Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Guggenheim reissued a "buy" rating and issued a $388.00 target price on shares of Cigna Group in a research note on Friday, May 23rd. Robert W. Baird decreased their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Finally, Mizuho boosted their target price on Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of "Buy" and a consensus price target of $380.39.
Read Our Latest Report on Cigna Group
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories

Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.